Applications for this job are now closed
For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
IMPORTANT: In order to be considered for this position, a resume/CV must be uploaded and submitted during the application process. Please make sure work history and education are added correctly.
The rle
Charles River Laboratories is one of the world’s largest contract research organisations focused on improving human and animal health by supporting the development of drugs and agrochemicals from discovery through to market approval. Our customers include those in the Pharmaceutical, Biotechnology, Veterinary Medicine and Agrochemical sectors, as well as leading academic institutions and government research centres.
The Tranent facility provides services including toxicology, safety pharmacology, bioanalysis, metabolism, veterinary health, environmental sciences and biotechnology. As a result of rapid and ongoing expansion, particularly in toxicology, the Department of Toxicology Sciences is seeking to recruit Scientific Associates.
We wish to recruit suitable graduates into our Study Director training programme and progression scheme. This will involve an initial period of formal training which must be successfully completed before assignment to the role of Study Director.
Once trained as a Study Director you will be responsible for the organisation, running and reporting of GLP safety assessment studies for submission to regulatory authorities. You will liaise closely with customers to interpret their requirements, ensure that studies meet their needs and are completed to agreed schedules.
Minimum requirements
- Biology based degree, a post graduate qualification in toxicology or pharmacology would be useful.
- Personal characteristics are also important for this role and we are looking for individuals who can demonstrate their commitment, proactivity and understanding of customer focus
- Effective communication, organisational and interpersonal skills.
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles River
Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.
